Supernus to Present at the 2022 Wells Fargo Healthcare Conference

ROCKVILLE, Md., Aug. 31, 2022 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | August 31, 2022

Related Keywords

Rockville ,Massachusetts ,United States ,Jack Khattar ,Jacka Khattar ,Timothyc Dec ,Peter Vozzo ,Exchange Commission ,Securities Exchange ,Supernus Pharmaceuticals Inc ,Supernus Pharmaceuticals ,Nasdaq ,Wells Fargo ,Fargo Healthcare Conference ,Encore Boston Harbor ,Investor Relations ,Private Securities Litigation Reform Act ,Securities Exchange Act ,Senior Vice President ,Nc Stock Exchange ,News ,Information ,Press Release ,022 ,Supernus ,Iopharmaceutical ,Company ,Ocused ,N ,Developing ,End ,Commercializing ,Products ,Or ,The ,Treatment ,F ,Central ,Nervous ,Ystem Supn Us8684591089 ,